Search Orphan Drug Designations and Approvals
-
Generic Name: | Adeno-associated viral vector serotype 9 encoding human ATP7B |
---|---|
Date Designated: | 12/07/2020 |
Orphan Designation: | Treatment of Wilson's Disease |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Ultragenyx Pharmaceutical Inc. 840 Memorial Drive Cambridge, Massachusetts 02139 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-